Clinical trial
Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods
NCT00180141 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods
- Lead sponsor
- Technische Universität Dresden
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- June 30, 2007
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis